Topic

pharma

5 articles

EDE approves once-daily RINVOQ for vitiligo patients aged 12+ in UAE

The UAE is first to approve oral RINVOQ for eligible non-segmental vitiligo. Clinics and insurers now need protocols, pricing checks and prior authorisation rules.

21 Aug 2026 · 3 min read

EDE approves once-daily RINVOQ for vitiligo patients aged 12+ in UAE

Regulatory & Policy

Burjeel treats first Camizestrant patient after UAE approval

Burjeel Cancer Institute gave Camizestrant to the world’s first clinical-care patient on 17 June 2026, six days after UAE approval.

17 Jun 2026 · 3 min read

Burjeel treats first Camizestrant patient after UAE approval

Regulatory & Policy

7-country WION report puts UAE controlled-medicine controls on COO agenda

WION's 7-country drug penalty report points to a practical UAE risk: controlled-medicine governance can affect licensing, procedures and board oversight.

11 Jun 2026 · 3 min read

7-country WION report puts UAE controlled-medicine controls on COO agenda

Regulatory & Policy

EDE clears AstraZeneca Etcamah after 55% PFS risk cut, ahead of FDA decision

EDE’s Etcamah approval gives UAE oncology leaders a 2026 formulary and testing decision: whether to fund serial ESR1 monitoring before radiographic progression.

11 Jun 2026 · 3 min read

EDE clears AstraZeneca Etcamah after 55% PFS risk cut, ahead of FDA decision

Regulatory & Policy

UAE mandates AED 1 million fine for medical product violations

Federal Decree-Law No. 8 of 2024 requires medical product companies to meet new manufacturing and distribution standards or face AED 1 million fines.

18 Mar 2026 · 2 min read

UAE mandates AED 1 million fine for medical product violations